Content area
Abstract
Post-approval evidence generation is essential for high-quality clinical care and should be a shared priority for clinicians, health systems, payors, and the medical products industry, as well as the FDA and federal agencies.
Details
Title
Post-approval evidence generation: a shared responsibility for healthcare
Author
Abbasi, Ali 1 ; Rivera, Donna 1 ; Curtis, Lesley H. 1 ; Califf, Robert M. 1
1 US Food and Drug Administration, Silver Spring, USA (GRID:grid.417587.8) (ISNI:0000 0001 2243 3366)
1 US Food and Drug Administration, Silver Spring, USA (GRID:grid.417587.8) (ISNI:0000 0001 2243 3366)
Pages
3046-3049
Publication year
2024
Publication date
Nov 2024
ISSN
10788956
e-ISSN
1546170X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3128462512
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.